Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
10.19
-0.80 (-7.28%)
May 13, 2025, 4:00 PM - Market closed

Syndax Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
153.99154.08295.3974.36221.97115.24
Upgrade
Short-Term Investments
362.32428.83282.19410.04224.87182.51
Upgrade
Cash & Short-Term Investments
516.31582.91577.58484.4446.83297.75
Upgrade
Cash Growth
16.51%0.92%19.24%8.41%50.07%387.54%
Upgrade
Accounts Receivable
15.727.6----
Upgrade
Other Receivables
5.766.271.234.060.430.2
Upgrade
Receivables
21.4813.871.234.060.430.2
Upgrade
Inventory
7.370.37---0.06
Upgrade
Prepaid Expenses
3.055.321.220.870.43
Upgrade
Restricted Cash
----0.120.12
Upgrade
Other Current Assets
0.540.610.060.120.150.32
Upgrade
Total Current Assets
548.75603.06580.88489.79448.4298.86
Upgrade
Property, Plant & Equipment
1.82.021.51.061.260.48
Upgrade
Long-Term Investments
89.94119.5229.835.47--
Upgrade
Other Long-Term Assets
0.220.220.680.92-1.27
Upgrade
Total Assets
640.71724.82612.88497.24449.66300.61
Upgrade
Accounts Payable
10.0511.639.964.355.673.51
Upgrade
Accrued Expenses
57.2159.6838.9723.6712.7611.25
Upgrade
Current Portion of Long-Term Debt
14.1512.12---2.29
Upgrade
Current Portion of Leases
0.380.481.050.440.360.32
Upgrade
Current Unearned Revenue
-----1.52
Upgrade
Other Current Liabilities
12.7619.658.120.61.89-
Upgrade
Total Current Liabilities
94.55103.5558.129.0720.6818.87
Upgrade
Long-Term Debt
329.64331.57--19.917.83
Upgrade
Long-Term Leases
1.451.580.590.720.710.1
Upgrade
Long-Term Unearned Revenue
-----11.62
Upgrade
Other Long-Term Liabilities
-----0
Upgrade
Total Liabilities
425.65436.6958.6829.7941.2948.43
Upgrade
Common Stock
0.010.010.010.010.010.01
Upgrade
Additional Paid-In Capital
1,5211,5091,4561,161952.02820.82
Upgrade
Retained Earnings
-1,306-1,221-902.4-693.04-543.7-568.63
Upgrade
Comprehensive Income & Other
0.530.160.22-0.810.05-0
Upgrade
Total Common Equity
215.06288.12554.2467.45408.37252.19
Upgrade
Shareholders' Equity
215.06288.12554.2467.45408.37252.19
Upgrade
Total Liabilities & Equity
640.71724.82612.88497.24449.66300.61
Upgrade
Total Debt
345.63345.741.641.1620.9720.54
Upgrade
Net Cash (Debt)
170.68237.17575.95483.24425.86277.21
Upgrade
Net Cash Growth
-61.36%-58.82%19.19%13.47%53.62%360.68%
Upgrade
Net Cash Per Share
1.992.778.187.957.946.71
Upgrade
Filing Date Shares Outstanding
86.0586.0284.9768.4455.0148.24
Upgrade
Total Common Shares Outstanding
86.0585.6984.8368.1154.9847.88
Upgrade
Working Capital
454.2499.51522.78460.72427.71279.99
Upgrade
Book Value Per Share
2.503.366.536.867.435.27
Upgrade
Tangible Book Value
215.06288.12554.2467.45408.37252.19
Upgrade
Tangible Book Value Per Share
2.503.366.536.867.435.27
Upgrade
Machinery
-0.250.250.250.540.41
Upgrade
Leasehold Improvements
-0.170.170.170.170.17
Upgrade
Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q